ArticleInvestigational new drugs2022

AM22, a novel synthetic microRNA, inhibits the proliferation of colorectal cancer cells by targeting core binding factor subunit β (CBFB).

Fanyi Meng et al.PubMed ↗Publisher ↗

No numbers read from the abstract.